tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graig Suvannavejh, 123 are a BUY (64.74%), 60 are a HOLD (31.58%), 7 are a SELL (3.68%).
Analyst Graig Suvannavejh, currently employed at MIZUHO, carries an average stock price target met ratio of 60.91% that have a potential upside of 34.67% achieved within 113 days.
Graig Suvannavejh’s has documented 390 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 07-Apr-2025.
Analyst best performing recommendations are on EYPT (EYEPOINT PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) at 11/2/2023. The price target of $20 was fulfilled within 35 days with a profit of $12.71 (174.35%) receiving and performance score of 49.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$7
$5.86 (514.04%)
1 months 30 days ago
(27-Feb-2025)
0/5 (0%)
$5.34 (321.69%)
Hold
$4
$2.86 (250.88%)
$15
4 months 10 days ago
(16-Dec-2024)
1/4 (25%)
$2.02 (102.02%)
128
Sell
$3
$1.86 (163.16%)
$10
5 months ago
(26-Nov-2024)
1/6 (16.67%)
$0.43 (16.73%)
332
Buy
$5
$3.86 (338.60%)
$16
5 months ago
(26-Nov-2024)
1/3 (33.33%)
$2.43 (94.55%)
70
Buy
5 months ago
(26-Nov-2024)
0/1 (0%)
$6.12 (88.95%)
Which stock is Graig Suvannavejh is most bullish on?
Which stock is Graig Suvannavejh is most reserved on?
What Year was the first public recommendation made by Graig Suvannavejh?
